Efficacy of QCDCR Formulated Cpg ODN 2007 in Nile Tilapia Against Streptococcus Iniae and Identification of Upregulated Genes
Total Page:16
File Type:pdf, Size:1020Kb
Veterinary Immunology and Immunopathology 145 (2012) 179–190 Contents lists available at SciVerse ScienceDirect Veterinary Immunology and Immunopathology j ournal homepage: www.elsevier.com/locate/vetimm Research paper Efficacy of QCDCR formulated CpG ODN 2007 in Nile tilapia against Streptococcus iniae and identification of upregulated genes a,∗ a a b Julia W. Pridgeon , Phillip H. Klesius , Xingjiang Mu , Robert J. Yancey , b b Michele S. Kievit , Paul J. Dominowski a Aquatic Animal Health Research Unit, USDA-ARS, 990 Wire Road, Auburn, AL 36832, United States b Pfizer Inc., Veterinary Medicine Research and Development, 333 Portage Street, Kalamazoo, MI 49007, United States a r t i c l e i n f o a b s t r a c t Article history: The potential of using a QCDCR (quilA:cholesterol:dimethyl dioctadecyl ammonium bro- Received 26 August 2011 mide:carbopol:R1005 glycolipid) formulated CpG oligodeoxynucleotide (ODN), ODN 2007, Received in revised form 31 October 2011 to confer protection in Nile tilapia against Streptococcus iniae infection was evaluated in Accepted 3 November 2011 this study. At two days post treatment, QCDCR formulated ODN 2007 elicited significant (P < 0.05) protection to Nile tilapia, with relative percent survival of 63% compared to fish Keywords: treated by QCDCR alone. To understand the molecular mechanisms involved in the protec- Streptococcus iniae tive immunity elicited by ODN 2007, suppression subtractive cDNA hybridization technique Oreochromis niloticus was used to identify upregulated genes induced by ODN 2007. A total of 69 expressed Subtractive hybridization Upregulation sequence tags (ESTs) were identified from the subtractive cDNA library. Quantitative PCR CpG oligodeoxynucleotide revealed that 44 ESTs were significantly (P < 0.05) upregulated by ODN 2007, including 29 highly (>10-fold) and 15 moderately (<10-fold) upregulated ESTs. Of all ESTs, putative peroxisomal sarcosine oxidase was upregulated the highest. The 69 ESTs only included six genes that had putative functions related to immunity, of which only two (putative glutaredoxin-1 and carboxypeptidase N catalytic chain) were confirmed to be significantly upregulated. Our results suggest that the protection elicited by ODN 2007 is mainly through innate immune responses directly or indirectly related to immunity. © 2011 Published by Elsevier B.V. 1. Introduction et al., 2010). This bacterium has also been identified as a potential zoonotic pathogen. An outbreak in Toronto traced Streptococcus iniae is a significant worldwide fish back to S. iniae infected tilapia was called “mad fish dis- pathogen causing significant economic losses to the aqua- ease” by the local press (Weinstein et al., 1996). To date, at culture industry worldwide. Originally isolated in 1976 least 25 cases of human infection by S. iniae has been con- from Amazon freshwater dolphin (Inia geoffrensis) (Pier and firmed (Weinstein et al., 1997; Koh et al., 2004; Agnew and Madin, 1976), S. iniae has become a major aetiological agent Barnes, 2007; Sun et al., 2007). Estimated economic impact of streptococcosis in farmed and wild finfish worldwide. on aquaculture industry due to infections caused by S. iniae Streptococcosis affects more than 30 species of fish, includ- is approximately $ 10 million in the USA alone and more ing trout, yellowtail, tilapia, barramundi, and hybrid striped than US $ 100 million globally (Shoemaker et al., 2010). bass (Bromage et al., 1999; Eldar et al., 1999; Ferguson et al., Methods to prevent streptococcal diseases in fish 2000; Agnew and Barnes, 2007; Eyngor et al., 2008; Cheng include the use of antibiotics-medicated food (Darwish, 2007), vaccines (Shoemaker et al., 2010), and immunos- timulatory oligonucleotides (Li et al., 2004). Unmethylated ∗ cytosine–phosphate–guanine (CpG) dinucleotides flanked Corresponding author. Tel.: +1 334 887 3741; fax: +1 334 887 2983. E-mail address: [email protected] (J.W. Pridgeon). by specific bases in bacterial DNA are recognized by the 0165-2427/$ – see front matter © 2011 Published by Elsevier B.V. doi:10.1016/j.vetimm.2011.11.001 180 J.W. Pridgeon et al. / Veterinary Immunology and Immunopathology 145 (2012) 179–190 immune system of vertebrates as danger signals, thus 2.2. Oligonucleotide and formulations inducing favorable immune responses in the host against infection (Krieg, 2002). Synthetic oligodeoxynucleotides ODN 2007 (TCGTCGTTGTCGTTTTGTCGTT; CpG motifs (ODNs) containing CpG motifs have been reported to are underlined) containing unmethylated CpG dinu- be capable of inducing protection against different dis- cleotides was synthesized by Qiagen-GmbH (Hilden, eases in various fish species, including S. iniae infection Germany). A stock of ODN 2007 was prepared in sterile in hybrid striped bass (Morone chrysops × Morone saxatilis) 10 mM phosphate buffered saline (PBS) at concentration (Li et al., 2004), Edwardsiella tarta in olive flounder (Par- of 20 mg/ml. The ODN 2007 was then diluented in QCDC alichthys olivaceus) (Lee et al., 2003), amoebic gill diseases carrier/adjuvant solution containing quilA (20 g/ml), in Atlantic salmon (Salmo salar) (Bridle et al., 2003), and cholesterol (20 g/ml), dimethyl dioctadecyl ammonium Aeromonas salmonicida in rainbow trout (Oncorhynchus bromide (10 g/ml), carbopol (0.05%, v/v) or QCDCR (QCDC mykiss) (Carrington and Secombes, 2007). Mechanisms plus R1005 glycolipid (100 g/ml). As negative control, a of protection induced by ODNs in fish include increased non-CpG ODN 21 (TTTAGTGAGGTCCTCGGATCA) was also serum lysozyme activity (Carrington and Secombes, 2007), included in this study to determine whether the non-CpG elevated respiratory burst activity of kidney phagocytes ODN has any protective effect in Nile tilapia against S. iniae (Lee et al., 2003), upregulation of TLR9 (Skjaeveland et al., infection. 2008), IL-1beta, Mx, TGFbeta, and Gal8 (Cuesta et al., 2008). However, whether synthetic ODNs are also capable of 2.3. Protective effect of ODN 2007 in Nile tilapia against inducing protection in Nile tilapia (Oreochromis niloticus) S. iniae infection against S. iniae infection has not been previously reported. ODN 2007, a B-class ODN, has been previously demon- All Nile tilapia were acclimated for at least 14 days strated to be able to induce a strong and balanced immune before the experiments. Fish were divided into nine groups response in cattle (Ioannou et al., 2002). Adjuvant such as in trial I and trial II (1: PBS control; 2: PBS + ODN 21; 3: QCDC has been reported to be able to enhance the pro- PBS + ODN 2007; 4: QCDC adjuvant control; 5: QCDC + ODN tective immunity of recombinant protein vaccine profilin 21; 6: QCDC + ODN 2007; 7: QCDCR adjuvant control; 8: in chicken against Eimeria maxima infection compared to QCDCR + ODN 21; 9: QCDCR + ODN 2007) (20 fish/group, animals immunized with profilin alone (Lee et al., 2010). three replicates per group) to determine which formu- However, it is currently unknown whether ODN 2007 by lation provided the best protection. In trial III, fish were itself or with an adjuvant such as QCDC could be used to divided into three groups (1: QCDCR adjuvant control; 2: protect Nile tilapia against S. iniae infections. Therefore, the QCDCR + ODN 21; 3: QCDCR + ODN 2007) (20 fish/group, objectives of this study were: (1) To determine whether three replicates per group). For CpG treatment group, ODN 2007 itself was capable of inducing protection in Nile 100 g of CpG (5 l of ODN stock) mixed with 95 l of tilapia against S. iniae infection; (2) To determine whether diluents (PBS or QCDC or QCDCR) was intraperitoneally (IP) QCDC adjuvant or modified QCDC formulation was capa- injected to each fish. For adjuvant control group, 5 l of PBS ble of enhancing the protective activity of ODN 2007 in mixed with 95 l of diluents (PBS or QCDC or QCDCR) was Nile tilapia against S. iniae infection; and (3) To identify IP injected to each fish. All fish were challenged with S. iniae upregulated genes induced by formulated ODN 2007 in Nile at two days post treatment. A virulent strain of S. iniae ARS- tilapia if the formulated ODN 2007 was able to enhance the 60 (Pridgeon and Klesius, 2011b), originally isolated from protection to Nile tilapia against S. iniae infection. diseased hybrid striped bass (M. saxatilis × M. chrysops) in 2004 and confirmed to be S. iniae by FAME analysis, was 2. Materials and methods used for the challenge assay. The archived S. iniae ARS- 60 strain was recovered from frozen stocks (2 ml aliquots ◦ − 2.1. Experimental fish stored at 80 C) and grown in tryptic soy broth (TSB) ◦ (Fisher Scientific, Pittsburgh, PA) for 24 h at 28 C. An optical Nile tilapia (22 ± 4 g) were obtained from stocks main- density (OD) of 1.0 of overnight S. iniae culture was mea- tained at USDA-ARS, Aquatic Animal Health Research sured at 540 nm using a spectrophotomer (Fisher Scientific, Laboratory (Auburn, AL, USA). All fish were maintained Pittsburgh, PA). A total of 100 l of the bacterial culture 8 × in dechlorinated city water in 340 l tanks. All fish were at approximately 2 10 colony forming unit (CFU) per remained naïve to S. iniae infections, which was confirmed ml was IP injected to each fish. Mortalities were recorded as culture negative using both anterior kidney and pos- daily for 15 days post exposure to S. iniae. The presence terior kidney tissue samples randomly collected from the or absence of S. iniae in challenged fish (dead fish when fish stock. Prior to experiments, fish were acclimated in discovered or live fish at the end of experiments) was deter- −1 flow-through 57 l aquaria supplied with ∼0.5 l h dechlo- mined from bacterial culture derived from the kidney sam- rinated water for 14 days. A 12:12 h light:dark period was ples on blood agar plates followed by fatty acid methyl ester maintained and supplemental aeration was supplied by (FAME) analysis through MIDI microbial identification gas −1 ∼ an air stone.